BRIAN GAYNOR: The rise and rise of Fisher & Paykel Healthcare

BRIAN GAYNOR: The rise and rise of Fisher & Paykel Healthcare
Brian Gaynor
Fisher & Paykel Healthcare has been a fantastic investment in recent years, particularly during the covid-19 pandemic.At the end of June, the medical supplies company had a share market value of $20.5 billion, making it the first $20 billion NZX company. Its performance during the covid-19 crisis has been amazing with its total market value surging $7.1 billion between Jan. 31 and June 30. This value accretion was greater than the total value of all but four other NZX listed stocks: A2 Milk, Meridian Energy, Auckland International...

More Opinion

The Government's Bunny Budget
Opinion

Cameron Bagrie: The Government's Bunny Budget

Budget 2026 is going to be the real test of this Government’s fiscal credentials.

ABL – Always be learning
Opinion

Simon Robertson: ABL – Always be learning

"If you see something interesting and are early, learn it fast, maybe buy it."

Simon Robertson 24 May 2025
The elephant in the room
Policy Opinion

Katrina Van Houtte: The elephant in the room

Budget 2025: Cross-parliamentary consensus is needed for infrastructure projects to flow.